These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10076573)

  • 21. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
    Farid RS; Bianchi ME; Falciola L; Engelsberg BN; Billings PC
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):532-9. PubMed ID: 8975778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line.
    Nakagawa M; Nomura Y; Kohno K; Ono M; Mizoguchi H; Ogata J; Kuwano M
    J Urol; 1993 Dec; 150(6):1970-3. PubMed ID: 8230547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Masumoto N; Fujishima H; Niho Y
    Int J Cancer; 1996 Feb; 65(4):479-84. PubMed ID: 8621231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
    Fukuda M; Nishio K; Kanzawa F; Ogasawara H; Ishida T; Arioka H; Bojanowski K; Oka M; Saijo N
    Cancer Res; 1996 Feb; 56(4):789-93. PubMed ID: 8631015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line.
    Saburi Y; Nakagawa M; Ono M; Sakai M; Muramatsu M; Kohno K; Kuwano M
    Cancer Res; 1989 Dec; 49(24 Pt 1):7020-5. PubMed ID: 2479474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
    Teicher BA; Holden SA; Herman TS; Sotomayor EA; Khandekar V; Rosbe KW; Brann TW; Korbut TT; Frei E
    Int J Cancer; 1991 Jan; 47(2):252-60. PubMed ID: 1846350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.
    Caliaro MJ; Vitaux P; Lafon C; Lochon I; Néhmé A; Valette A; Canal P; Bugat R; Jozan S
    Br J Cancer; 1997; 75(3):333-40. PubMed ID: 9020476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Existence of a transcription factor for the human HMG2 gene positively related to the level of HMG2 mRNA in the cells.
    Shirakawa H; Yoshida M
    Biochemistry; 1995 Feb; 34(8):2521-7. PubMed ID: 7873532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
    Kunii E; Oguri T; Kasai D; Ozasa H; Uemura T; Takakuwa O; Ohkubo H; Takemura M; Maeno K; Niimi A
    Cancer Chemother Pharmacol; 2015 May; 75(5):985-91. PubMed ID: 25772757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E; Groen HJ; Helder MN; de Vries EG; Meijer C
    Biochem Pharmacol; 2002 Jun; 63(11):1989-96. PubMed ID: 12093475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
    Sark MW; Timmer-Bosscha H; Meijer C; Uges DR; Sluiter WJ; Peters WH; Mulder NH; de Vries EG
    Br J Cancer; 1995 Apr; 71(4):684-90. PubMed ID: 7710929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ; Kelland LR; Harrap KR
    Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression.
    Satou M; Aizawa S; Hayakari M; Ookawa K; Tsuchida S
    Cancer Sci; 2003 Mar; 94(3):286-91. PubMed ID: 12824923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y; Nakamura M; Yokoo S
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ; Perez M; Kang H; Siddik ZH; Ling YH; Perez-Soler R
    Clin Cancer Res; 2000 Jan; 6(1):193-202. PubMed ID: 10656450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.